Effects of fenofibrate on semaphorin 6B gene expression in rat skeletal muscle

Molecular Medicine Reports

Volumn 4, Issue 3, 2011, Pages 575-580

  Murad, Hossam ^a   Kasies, Fadia ^a   Azroony, Raed ^a   Alya, Ghassan ^a   Madania, Ammar ^a  

^a DEPARTMENT OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Syrian Arab Republic)

Author keywords

Fenofibrate; Peroxisome proliferator response element; Peroxisome proliferator activated receptor ; Rat semaphorin

Indexed keywords

BETA ACTIN; FENOFIBRATE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SEMAPHORIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE EXPRESSION; MALE; NONHUMAN; PROMOTER REGION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; SKELETAL MUSCLE;

ANIMALS; CHROMATIN IMMUNOPRECIPITATION; COMPUTATIONAL BIOLOGY; FEMALE; FENOFIBRATE; GENE EXPRESSION REGULATION; MALE; MEMBRANE GLYCOPROTEINS; MUSCLE, SKELETAL; NERVE TISSUE PROTEINS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RATS; RATS, WISTAR; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

RATTUS;

EID: 79953797900     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.463     Document Type: Article

References (42)

1. Grinnell AD: Trophic interaction between nerve and muscle. In: Myology: Basic and Clinical. Vol 1. Engel AG and Franzini-Armstrong C (eds). McGraw Hill, New York, NY, pp303-332, 1994.
2. Windebank AJ and Mulder DW: Motor neuron disease in adults. in: Myology: Basic and Clinical. Vol 2. 2nd edition. Engel AG and Franzini-Armstrong C (eds). McGraw Hill, New York, NY, pp1854-1869, 1994.
3. Tamagnone L and Comoglio PM: Signalling by semaphorin receptors: cell guidance and beyond. Trends Cell Biol 10: 377-383, 2000. (Pubitemid 30612470)
4. Semaphorin Nomenclature Committee: Unifed nomenclature for the semaphorins/collapsins. Cell 97: 551-552, 1999.
5. Raper JA: Semaphorins and their receptors in vertebrates and invertebrates, Curr Opin Neurobiol 10: 88-94, 2000.
6. Serafni T, Kennedy TE, Galko MJ, Mirzayan C, Jessell TM and Tessier-Lavigne M: The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell 78: 409-424, 1994. (Pubitemid 24250806)
7. Holder N and Klein R: Eph receptors and ephrins: effectors of morphogenesis. Development 126: 2033-2044, 1999. (Pubitemid 29271689)
8. Kramer SG, Kidd T, Simpson JH and Goodman CS: Switching repulsion to attraction: changing responses to slit during transition in mesoderm migration. Science 292: 737-740, 2001. (Pubitemid 32385546)
9. Wu W, Wong K, Chen J, Jiang Z, Dupuis S, Wu JY and Rao Y: Directional guidance of neuronal migration in the olfactory system by the protein Slit. Nature 400: 315-316, 1999.
10. Luo Y, Raible D and Raper JA: Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 75: 217-227, 1993. (Pubitemid 23320286)
11. Kolodkin AL, Matthes DJ and Goodman CS: The semaphorin genes encode a family of transmembrane and secreted growth cone guidance. Cell 75: 1389-1399, 1993.
12. Tamagnone L, Artigiani S, Chen H, et al: Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99: 71-80, 1999. (Pubitemid 29468631)
13. Goodman CS, Kolodkin AL, Luo Y, Pueschel AW and Raper JA: Unifed nomenclature for the semaphorins collapsins. Cell 97: 551-552, 1999.
14. Toyofuku T, Zhang H, Kumanogoh A, et al: dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-tackand vascular endothelial growth factor receptor type 2. Genes Dev 18: 435-447, 2004. (Pubitemid 38316350)
15. Klostermann A, Lutz B, Gertler F and Behl C: The orthologous human and murine semaphorin 6A-1 proteins (SEMA6A-1/Sema6A-1) bind to the enabled/vasodilator-stimulated phosphoprotein-like protein (EVL) via a novel carboxyl-terminal zyxin-like domain. J Biol Chem 275: 39647-39653, 2000. (Pubitemid 32058992)
16. Kikuchi K, Ishida H and Kimura T: Molecular cloning of a novel member of semaphorin family genes, semaphorin Z. Brain Res Mol Brain Res 51: 229-237, 1997. (Pubitemid 27504048)
17. Eckhardt F, Behar O, Calautti E, Yonezawa K, Nishimoto I and Fishman MC: a novel transmembrane semaphorin can bind c-src. Mol Cell Neurosci 9: 409-419, 1997. (Pubitemid 27467492)
18. Correa RG, Sasahara RM, Bengtson MH, et al: Human semaphorin 6B [(HSA)SEMA6B], a novel human class 6 semaphorin gene: alternative splicing and all-trans-retinoic acid-dependent downregulation in glioblastoma cell lines. Genomics 73: 343-348, 2001.
19. Collet P, Domenjoud L, Devignes Marie D, Murad H, Schohn H and Dauca M: The human semaphorin 6B gene is down regulated by PPARs. Genomics 83: 1141, 2004.
20. Murad H, Collet P, Huin-Schohn C, et al: Effects of PPAR and RXR ligands in semaphorin 6B gene expression of human MCF-7 breast cancer cells. Int J oncol 28: 977-984, 2006.
21. Nuclear Receptors Nomenclature Committee: A unifed nomenclature system for the nuclear receptor superfamily. Cell 97: 161-163, 1999.
22. Su JL, Simmons CJ, Wisely B, Ellis B and Winegar DA: Monitoring of PPAR alpha protein expression in human tissue by the use of PPAR alpha-specific MAbs. Hybridoma 17: 47-53, 1998. (Pubitemid 28120018)
23. Lee CH, Olson P and Evans RM: Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144: 2201-2207, 2003. (Pubitemid 36629867)
24. Reddy JK and Hashimoto T: Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr 21: 193-230, 2001. (Pubitemid 32695270)
25. Schoonjans K, Staels B and Auwerx J: Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 5: 907-925, 1996. (Pubitemid 26182326)
26. Rosenson RS: Current overview of statin-induced myopathy. Am J Med 116: 408-416, 2004.
27. Hodel C: Myopathy and rhabdomyolysis with lipid-lowering drugs. Toxicol Lett 128: 159-168, 2002.
28. Bannwarth B: Drug-induced myopathies. Expert Opin Drug Saf 1: 65-70, 2002.
29. Roca B, Calvo B and Monferrer R: Severe rhabdomyolysis and cerivastatin-gemfibrozil combination therapy. Ann Pharmacother 36: 730-731, 2002. (Pubitemid 34270296)
30. Jones PH and Davidson MH: Reporting rate of rhabdomyolysis with fenofbrate + statin versus gemfibrozil + any statin. Am J Cardiol 95: 120-122, 2005. (Pubitemid 40051126)
31. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
32. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
33. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
34. Podvinec M, Kaufmann Mr, Handschin C and Meyer UA: NUBIScan, an in silico approach for prediction of nuclear receptor response elements. Mol endocrinol 16: 1269-1279, 2002. (Pubitemid 34621075)
35. Mandard S, Muller M and Kersten S: Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci 61: 393-416, 2004. (Pubitemid 38316578)
36. Tatsumi R, Sankoda Y, Anderson JE, et al: Possible implication of satellite cells in regenerative motoneuritogenesis: HGF upregulates neural chemorepellent Sema3A during myogenic differentiation. Am J Physiol Cell Physiol 297: C238-C252, 2009.
37. McLoon LK: a new role for satellite cells: control of reinnervation after muscle injury by semaphorin 3A. Focus on 'possible implication of satellite cells in regenerative motoneuritogenesis: HGF upregulates neural chemorepellent Sema3A during myogenic differentiation'. Am J Physiol Cell Physiol: Jun 17, 2009 (E-pub ahead of print).
38. De Winter F, Vo T, Stam FJ, et al: The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol Cell Neurosci 32: 102-117, 2006. (Pubitemid 43868100)
39. Wu H, Wang X, Liu S, et al: Sema4C participates in myogenic differentiation in vivo and in vitro through the p38 MAPK pathway. Eur J Cell Biol 86: 331-344, 2007. (Pubitemid 46825256)
40. Qu X, Wei H, Zhai Y, et al: Identification, characterization, and functional study of the two novel human members of the semaphorin gene family. J Biol Chem 277: 35574-35585, 2002.
41. Svensson A, Libelius R and Tagerud S: Semaphorin 6C expression in innervated and denervated skeletal muscle. J Mol Histol 39: 5-13, 2008.
42. Suto F, Ito K, Uemara M, et al: Plexin-a4 mediates axon-repulsive activities of both secreted and transmembrane semaphorins and plays roles in nerve fber guidance. J Neurosci 6: 3628-3637, 2005.